• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Increased PARP-1 association with DNA in alkylation damaged, PARP-inhibited mouse fibroblasts.在烷化损伤、PARP 抑制剂抑制的小鼠成纤维细胞中,PARP-1 与 DNA 的结合增加。
Mol Cancer Res. 2012 Mar;10(3):360-8. doi: 10.1158/1541-7786.MCR-11-0477. Epub 2012 Jan 13.
2
Preventing oxidation of cellular XRCC1 affects PARP-mediated DNA damage responses.防止细胞 XRCC1 的氧化会影响 PARP 介导的 DNA 损伤反应。
DNA Repair (Amst). 2013 Sep;12(9):774-85. doi: 10.1016/j.dnarep.2013.06.004. Epub 2013 Jul 18.
3
Alkylation DNA damage in combination with PARP inhibition results in formation of S-phase-dependent double-strand breaks.烷化 DNA 损伤与 PARP 抑制相结合会导致 S 期依赖性双链断裂的形成。
DNA Repair (Amst). 2010 Aug 5;9(8):929-36. doi: 10.1016/j.dnarep.2010.05.007. Epub 2010 Jun 22.
4
Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts.聚(ADP - 核糖)聚合酶 -1可保护人类细胞提取物修复过程中过度的DNA链断裂免于恶化。
FEBS J. 2005 Apr;272(8):2012-21. doi: 10.1111/j.1742-4658.2005.04628.x.
5
Poly(ADP-ribose) polymerase activity prevents signaling pathways for cell cycle arrest after DNA methylating agent exposure.聚(ADP - 核糖)聚合酶活性可阻止DNA甲基化剂暴露后细胞周期停滞的信号通路。
J Biol Chem. 2005 Apr 22;280(16):15773-85. doi: 10.1074/jbc.M413841200. Epub 2005 Feb 7.
6
Role of poly(ADP-ribose) polymerase-1 in the removal of UV-induced DNA lesions by nucleotide excision repair.聚(ADP-核糖)聚合酶 1 在核苷酸切除修复中清除 UV 诱导的 DNA 损伤的作用。
Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1658-63. doi: 10.1073/pnas.1209507110. Epub 2013 Jan 14.
7
p21CDKN1A participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1.p21CDKN1A 通过调节聚(ADP-核糖)聚合酶-1 的活性参与碱基切除修复。
DNA Repair (Amst). 2010 Jun 4;9(6):627-35. doi: 10.1016/j.dnarep.2010.02.011. Epub 2010 Mar 19.
8
p21CDKN1A Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates.p21CDKN1A调控聚(ADP - 核糖)聚合酶-1与DNA修复中间体的结合。
PLoS One. 2016 Jan 5;11(1):e0146031. doi: 10.1371/journal.pone.0146031. eCollection 2016.
9
Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair.抑制多聚(ADP-核糖)聚合酶可增强细胞中对辐射和烷化剂的敏感性,而这种细胞缺乏 DNA 双链断裂修复。
Mol Cancer Ther. 2010 Jun;9(6):1775-87. doi: 10.1158/1535-7163.MCT-09-1027. Epub 2010 Jun 8.
10
Hyperactivation of PARP triggers nonhomologous end-joining in repair-deficient mouse fibroblasts.PARP 的过度激活触发修复缺陷型小鼠成纤维细胞中的非同源末端连接。
PLoS One. 2012;7(11):e49301. doi: 10.1371/journal.pone.0049301. Epub 2012 Nov 7.

引用本文的文献

1
Poly (ADP-ribose) polymerase in yeasts: characterization and involvement in telomere maintenance.酵母中的聚(ADP - 核糖)聚合酶:特性及在端粒维持中的作用
Nucleic Acids Res. 2025 Sep 5;53(17). doi: 10.1093/nar/gkaf837.
2
Druggable Molecular Networks in -Mutated Breast Cancer.-突变乳腺癌中的可药物作用分子网络
Biology (Basel). 2025 Mar 2;14(3):253. doi: 10.3390/biology14030253.
3
Impact of PARP inhibitors on progression-free survival in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective analysis.聚腺苷二磷酸核糖聚合酶抑制剂对铂类敏感复发性上皮性卵巢癌无进展生存期的影响:一项回顾性分析。
World J Surg Oncol. 2024 Oct 21;22(1):276. doi: 10.1186/s12957-024-03562-8.
4
A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway.一种用于发现端粒替代延长(ALT)途径调节剂的首创高通量筛选方法。
ACS Pharmacol Transl Sci. 2024 Aug 13;7(9):2799-2819. doi: 10.1021/acsptsci.4c00251. eCollection 2024 Sep 13.
5
Inhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer.抑制 PRMT5 可诱导 DNA 损伤,并增加 PARP 抑制剂尼拉帕利在乳腺癌和卵巢癌模型中的抗增殖活性。
BMC Cancer. 2023 Aug 18;23(1):775. doi: 10.1186/s12885-023-11260-z.
6
The function and regulation of ADP-ribosylation in the DNA damage response.ADP-核糖基化在 DNA 损伤反应中的功能和调节。
Biochem Soc Trans. 2023 Jun 28;51(3):995-1008. doi: 10.1042/BST20220749.
7
Targeting the / deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights.用聚(ADP-核糖)聚合酶(PARP)抑制剂靶向缺陷型癌症:临床结果与机制洞察
Front Cell Dev Biol. 2023 Mar 22;11:1133472. doi: 10.3389/fcell.2023.1133472. eCollection 2023.
8
Current status and future promise of next-generation poly (ADP-Ribose) polymerase 1-selective inhibitor AZD5305.下一代聚(ADP-核糖)聚合酶1选择性抑制剂AZD5305的现状与未来前景
Front Pharmacol. 2023 Jan 23;13:979873. doi: 10.3389/fphar.2022.979873. eCollection 2022.
9
Dynamics of endogenous PARP1 and PARP2 during DNA damage revealed by live-cell single-molecule imaging.活细胞单分子成像揭示DNA损伤过程中内源性PARP1和PARP2的动态变化
iScience. 2022 Dec 9;26(1):105779. doi: 10.1016/j.isci.2022.105779. eCollection 2023 Jan 20.
10
Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer.PARP1 癌基因自主过激活破坏非小细胞肺癌的免疫监视
J Immunother Cancer. 2022 Jun;10(6). doi: 10.1136/jitc-2021-004280.

本文引用的文献

1
The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings.PARP 和 BRCA 合成致死的潜在机制:澄清误解。
Mol Oncol. 2011 Aug;5(4):387-93. doi: 10.1016/j.molonc.2011.07.001. Epub 2011 Jul 22.
2
PARP inhibitors in cancer therapy: promise, progress, and puzzles.聚腺苷二磷酸核糖聚合酶抑制剂在癌症治疗中的应用:前景、进展与困惑。
Cancer Cell. 2011 Feb 15;19(2):165-7. doi: 10.1016/j.ccr.2011.01.047.
3
Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate.聚(ADP-核糖)聚合酶(PARP)不参与碱基切除修复,但 PARP 抑制会捕获单链中间体。
Nucleic Acids Res. 2011 Apr;39(8):3166-75. doi: 10.1093/nar/gkq1241. Epub 2010 Dec 22.
4
Requirement for NBS1 in the S phase checkpoint response to DNA methylation combined with PARP inhibition.NBS1 在 DNA 甲基化联合 PARP 抑制的 S 期检查点反应中的需求。
DNA Repair (Amst). 2011 Feb 7;10(2):225-34. doi: 10.1016/j.dnarep.2010.11.003. Epub 2010 Dec 3.
5
Alkylation DNA damage in combination with PARP inhibition results in formation of S-phase-dependent double-strand breaks.烷化 DNA 损伤与 PARP 抑制相结合会导致 S 期依赖性双链断裂的形成。
DNA Repair (Amst). 2010 Aug 5;9(8):929-36. doi: 10.1016/j.dnarep.2010.05.007. Epub 2010 Jun 22.
6
Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair.抑制多聚(ADP-核糖)聚合酶可增强细胞中对辐射和烷化剂的敏感性,而这种细胞缺乏 DNA 双链断裂修复。
Mol Cancer Ther. 2010 Jun;9(6):1775-87. doi: 10.1158/1535-7163.MCT-09-1027. Epub 2010 Jun 8.
7
Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic.聚(ADP - 核糖)聚合酶 -1(PARP - 1)抑制剂的演变。从概念到临床应用。
J Med Chem. 2010 Jun 24;53(12):4561-84. doi: 10.1021/jm100012m.
8
Bioenergetic metabolites regulate base excision repair-dependent cell death in response to DNA damage.生物能量代谢物调节碱基切除修复依赖的细胞死亡以响应 DNA 损伤。
Mol Cancer Res. 2010 Jan;8(1):67-79. doi: 10.1158/1541-7786.MCR-09-0411. Epub 2010 Jan 12.
9
Poly(ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspective.聚(ADP-核糖)聚合酶抑制剂在癌症治疗中的应用:临床视角。
Eur J Cancer. 2010 Jan;46(1):9-20. doi: 10.1016/j.ejca.2009.10.021.
10
DNA polymerase beta and PARP activities in base excision repair in living cells.活细胞碱基切除修复中的DNA聚合酶β和PARP活性
DNA Repair (Amst). 2009 Nov 2;8(11):1290-9. doi: 10.1016/j.dnarep.2009.08.004. Epub 2009 Sep 12.

在烷化损伤、PARP 抑制剂抑制的小鼠成纤维细胞中,PARP-1 与 DNA 的结合增加。

Increased PARP-1 association with DNA in alkylation damaged, PARP-inhibited mouse fibroblasts.

机构信息

Laboratory of Structural Biology, National Institute of Environmental Health Sciences, NIH, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709, USA.

出版信息

Mol Cancer Res. 2012 Mar;10(3):360-8. doi: 10.1158/1541-7786.MCR-11-0477. Epub 2012 Jan 13.

DOI:10.1158/1541-7786.MCR-11-0477
PMID:22246237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3307909/
Abstract

Treatment of base excision repair-proficient mouse fibroblasts with the DNA alkylating agent methyl methanesulfonate (MMS) and a small molecule inhibitor of PARP-1 results in a striking cell killing phenotype, as previously reported. Earlier studies showed that the mechanism of cell death is apoptosis and requires DNA replication, expression of PARP-1, and an intact S-phase checkpoint cell signaling system. It is proposed that activity-inhibited PARP-1 becomes immobilized at DNA repair intermediates, and that this blocks DNA repair and interferes with DNA replication, eventually promoting an S-phase checkpoint and G(2)-M block. Here we report studies designed to evaluate the prediction that inhibited PARP-1 remains DNA associated in cells undergoing repair of alkylation-induced damage. Using chromatin immunoprecipitation with anti-PARP-1 antibody and qPCR for DNA quantification, a higher level of DNA was found associated with PARP-1 in cells treated with MMS plus PARP inhibitor than in cells without inhibitor treatment. These results have implications for explaining the extreme hypersensitivity phenotype after combination treatment with MMS and a PARP inhibitor.

摘要

先前有报道称,用 DNA 烷化剂甲磺酸甲酯(MMS)和 PARP-1 的小分子抑制剂处理碱基切除修复功能正常的小鼠成纤维细胞,会产生明显的细胞杀伤表型。早期研究表明,细胞死亡的机制是细胞凋亡,需要 DNA 复制、PARP-1 的表达和完整的 S 期检查点细胞信号系统。有人提出,失活的 PARP-1 会固定在 DNA 修复中间体上,从而阻断 DNA 修复并干扰 DNA 复制,最终促进 S 期检查点和 G2-M 阻滞。在这里,我们报告了旨在评估以下预测的研究结果:在经历烷化剂诱导损伤修复的细胞中,失活的 PARP-1 仍然与 DNA 相关联。使用抗 PARP-1 抗体的染色质免疫沉淀和 qPCR 进行 DNA 定量,结果发现,用 MMS 和 PARP 抑制剂处理的细胞中与 PARP-1 相关联的 DNA 水平高于未用抑制剂处理的细胞。这些结果对于解释 MMS 和 PARP 抑制剂联合治疗后的极度超敏表型具有重要意义。